The global paradigm for cardiovascular health has shifted decisively from reactive pharmacology to proactive metabolic regulation. In the functional nutrition and pharmaceutical industries, "Cholesterol Off" concepts represent a rapidly expanding sector targeting the modulation of low-density lipoprotein cholesterol (LDL-C), triglycerides, and overall cardiovascular health. Globally, hypercholesterolemia remains a major risk factor for coronary heart diseases. According to modern clinical paradigms, botanical extracts containing active bioflavonoids, phytosterols, and alkaloids offer pathways that parallel or synergistically support standard therapies like HMG-CoA reductase inhibitors.
The market for natural lipid-regulating ingredients is experiencing a compound annual growth rate (CAGR) of over 7.8% globally. Demand is concentrated heavily in aging populations across North America and Europe, as well as emerging health-conscious demographics in the Asia-Pacific region. As regulatory bodies enforce stricter monitoring on synthetic drugs, consumer demand has surged for plant-derived alternatives that demonstrate high efficacy with minimal side effects. Prominent bio-compounds such as Palmatine, Citrus Bergamot Extract, Magnolol, and Dihydroberberine have become foundational in formulation engineering for cholesterol management.
Natural cholesterol regulatory complexes function via multiple biological pathways: inhibiting cholesterol absorption in the intestines via phytosterols competition, activating AMP-activated protein kinase (AMPK) to down-regulate intracellular lipid synthesis, and optimizing hepatic LDL-receptor density for enhanced clearance of low-density lipoproteins.
Developing an effective "Cholesterol Off" product requires precise standardization of raw materials. Generic botanical powders often fail clinical evaluations due to natural variations in active molecules caused by soil composition, weather, and harvest timing.
Industrial manufacturers rely on advanced high-performance liquid chromatography (HPLC) and ultraviolet-visible spectrophotometry (UV-Vis) to isolate and guarantee consistent concentrations of targeted compounds. For instance, standardized Citrus Aurantium fractions require precise ratios of active flavonoids like Naringenin, which has been shown to downregulate apolipoprotein B secretion in hepatocytes. Similarly, custom purified *Salidroside* and *Dihydroberberine* fractions are processed to achieve target purity levels that meet global pharmacopoeia requirements.
Established in 2012, Chengdu Chenlv Herb Co., Ltd. is a high-tech enterprise specializing in the R&D, production, and sales of botanical extracts and natural pharmaceutical ingredients. Committed to providing high-purity, highly active, and premium-quality natural raw materials, we serve diverse industries including pharmaceuticals, health supplements, food, and cosmetics.
Pioneering the industrialization of high-purity botanical active ingredients for domestic and global markets.
Leveraging advanced extraction infrastructures, geographical supply chain proximity, and strict quality assurance frameworks to deliver global-grade ODM/OEM solutions.
Bridging the gap between agricultural active constituents and high-demand commercial wellness industries worldwide.
Driven by the concept of "homology of medicine and food" and modern health needs, plant extracts have become core raw materials for natural supplements, offering natural pathways for long-term health management.
From botanical formulas documented in historical medical texts to modern drug formulations, standardized plant extracts serve as active pharmaceutical ingredients (APIs) due to their consistent therapeutic effects.
With consumer demand centering on clean beauty and bio-compatibility, botanical extracts provide functional properties like antioxidant defense and skin barrier support for skincare formulations.
Plant extracts are increasingly utilized in animal feeds to support gut health and immunological resilience, serving as clean alternatives to chemical additives in modern animal husbandry.
Western China, particularly the Sichuan basin and Chengdu plains, forms an ecological hub for botanical cultivation. The region's geography provides natural conditions for growing a variety of therapeutic herbs, including *Cistanche Tubulosa*, *Citrus Aurantium*, and bergamot varieties. Sourcing raw materials from this region provides distinct logistical and economic benefits.
By positioning Chengdu Chenlv Herb Co., Ltd.'s processing facilities near these agricultural hubs, we establish a secure supply chain with reduced transport times. This close proximity helps preserve key active molecules from degradation that can occur during long-distance transport. Additionally, our regional supply model supports competitive, stable pricing by minimizing exposure to global freight volatility.
Our facility uses multi-stage countercurrent extraction units alongside continuous chromatography columns. This setup operates as a closed loop to maximize yield while reducing solvent waste. Automated temperature controls help prevent thermal degradation of sensitive compounds like Salidroside or Camptothecin.
A structured, reliable product development pipeline designed to bring your proprietary formulas from concept to commercial reality.
Consultation to align on target botanical compounds, therapeutic profile, and product specifications.
Detailed cost breakdown covering raw materials, custom extraction levels, and logistics options.
Formalizing partnership terms, including intellectual property protection, delivery schedules, and quality metrics.
R&D laboratory pilots and prototype creation to verify active ingredient concentrations.
Commercial-scale extraction using high-capacity automated production lines.
Analytical testing and verification to issue the batch Certificate of Analysis (CoA).
Secure global logistics management with full customs compliance documentation for target markets.
Our processes adhere to international standards to ensure product safety, quality, and traceablity.
Addressing key technical inquiries from global B2B procurement managers and formulation developers.
Stay informed with updates on phytochemical market trends and research developments.
Recently, the market price of Citrus aurantium raw materials in China has risen, drawing industry attention. As the production season ends, supply and demand dynamics and cost considerations are driving market adjustments.
We invite industry colleagues to connect at the 23rd China Pharmaceutical Raw Materials Exhibition (CPHI China 2025) to discuss new developments and sourcing opportunities.
Join our formulation experts at the upcoming API conference to discuss custom solutions for cholesterol management products.
For inquiries about our products, customization specifications, or to request a price list, please get in touch and we will reply within 24 hours.